Add BrightSurf on Google Email

Medical cannabis use in Australian patients with chronic health issues linked to significant improvements in overall health-related quality of life and fatigue levels

Medical cannabis use in Australian patients with chronic health issues is linked to significant improvements in overall health-related quality of life and fatigue levels. Patients also report clinically meaningful reductions in pain and moderate-severe anxiety and depression.

SourcePLOS·JournalPLOS ONE·TypeSurvey·DateSep 6, 2023

Study finds high blood and urinary metal levels among exclusive marijuana users

Research at Columbia University's Mailman School of Public Health detected significant levels of metals in the blood and urine of marijuana users, suggesting that marijuana is a source of lead and cadmium exposure. Measurements reported by participants showed higher lead levels in blood and urine among exclusive marijuana users compare...

SourceColumbia University's Mailman School of Public Health·JournalEnvironmental Health Perspectives·DateAug 30, 2023

In states that legalized cannabis, frequent cannabis use became more common in young adults who are not in college, OSU study finds

An Oregon State University study found that young adults not in college became more frequent users of cannabis and met criteria for cannabis use disorder after state legalization. The prevalence of frequent cannabis use increased by 5 percentage points among non-college young adults, while college students saw a smaller increase.

SourceOregon State University·JournalAmerican Journal of Preventive Medicine·TypeData/statistical analysis·DateAug 2, 2023

New study debunks claims of a psychedelic cannabinoid

A University at Buffalo-led study found that THC-O-acetate produces moderate relaxation, euphoria, and pain relief, but no psychedelic effects similar to LSD or psilocybin mushrooms. The study suggests that people may overreport their experiences due to social media hype and online claims.

SourceUniversity at Buffalo·JournalJournal of Psychoactive Drugs·TypeSurvey·DateJul 11, 2023

Cannabis use associated with increased risk of surgical complications, according to UTHealth Houston study

A UTHealth Houston study found that regular cannabis users are more likely to experience complications before, during, and after surgery. Patients with a cannabis use disorder (CUD) were approximately 20% more likely to suffer significant postoperative complications than those without CUD.

SourceUniversity of Texas Health Science Center at Houston·JournalJAMA Surgery·TypeData/statistical analysis·DateJul 5, 2023

State medical cannabis laws not associated with reduced use of opioid or nonopioid pain treatments

A study of commercially insured adults with chronic noncancer pain found that state medical cannabis laws did not lead to a reduction in the use of opioid or nonopioid pain treatments. The researchers also suggested slow implementation and reluctance among healthcare leaders may have contributed to these findings.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeData/statistical analysis·DateJul 3, 2023

Adverse childhood experiences are ‘strong predictor’ for adolescent cannabis use

A new study found that young people exposed to adverse childhood experiences between ages 0-12 are at high risk of developing problematic adolescent cannabis use. The research, led by Dr Lindsey Hines, analyzed outcomes for over 5,000 participants and found a strong correlation between ACEs and regular cannabis use in teenage years.

SourceUniversity of Bath·JournalThe Lancet Public Health·TypeObservational study·DateJun 29, 2023

UNM researchers find medical cannabis patients who feel 'high' report greater symptom relief but increased negative side effects

A new study by UNM researchers found that patients who reported feeling 'high' experienced 7.7% greater symptom relief, but also a more than 20% increase in negative side effects. The study suggests that feeling 'high' may be an unavoidable component of using cannabis medicinally.

SourceUniversity of New Mexico·JournalFrontiers in Pharmacology·TypeObservational study·DateJun 21, 2023

Drug to treat cannabis use disorder shows promise in clinical trial

A Phase 2a clinical trial found that AEFO117 significantly reduced the effects of cannabis in daily smokers and decreased both positive mood effects and decision to use cannabis. The drug, developed by Aelis Farma, appears to counteract the high associated with THC without disrupting physiological and behavioral functions.

SourceColumbia University Irving Medical Center·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateJun 8, 2023

New research may explain why, despite “the munchies”, frequent cannabis users are leaner than non-users

Researchers have uncovered a possible explanation for why frequent cannabis users are leaner and less prone to diabetes than non-users. The study found that adolescent exposure to low-dose THC disrupts energy balance and adipose organ homeostasis in adulthood, leading to reduced fat mass and increased lean mass.

SourceUniversity of California - Irvine·JournalCell Metabolism·DateJun 1, 2023

EMBARGOED: Mount Sinai Pulmonologists to Present New Research on Asthma and Sleep Disorders at ATS 2023 International Conference

Researchers from Mount Sinai Health System will present studies on pediatric pulmonary vascular disease, asthma, and sleep disorders. The findings focus on prevalence of pulmonary hypertension in children with severe obstructive sleep apnea and associations between diet and lung function decline.

Researchers analyze THC in breath of cannabis smokers

A study by NIST and University of Colorado Boulder collected breath samples from participants before and after smoking high-THC cannabis, revealing that distinguishing between recent use and past use remains challenging. The research aimed to develop a reproducible protocol for breath measurements, which will help answer key questions ...

SourceNational Institute of Standards and Technology (NIST)·JournalJournal of Breath Research·TypeExperimental study·DateMay 22, 2023

Is vaping a new gateway into further substance use? New national study shows adolescent vapers much likelier to use cannabis and binge drink

A new national study of over 50,000 US adolescents reveals a strong association between vaping nicotine and increased likelihood of high-level cannabis usage and binge drinking. The findings highlight the need for sustained interventions to address co-occurring substance use among young people.

SourceTaylor & Francis Group·JournalSubstance Use & Misuse·TypeObservational study·DateMay 18, 2023

Occasional cannabis use during pregnancy may be enough to impact fetal growth significantly

Research found that occasional cannabis use during early pregnancy can significantly reduce birth weight, even if continued use is not observed. Continued exposure results in largest deficiencies, with newborns exposed to marijuana throughout gestation being nearly 200g lighter and having smaller head circumferences.

SourceFrontiers·JournalFrontiers in Pediatrics·TypeObservational study·DateMay 16, 2023

Young men at highest risk of schizophrenia linked with cannabis use disorder

A recent NIH study reveals that young men with cannabis use disorder are at a higher risk of developing schizophrenia. The study analyzed health records data from over 6 million people in Denmark and found that as many as 30% of schizophrenia cases among young men aged 21-30 might have been prevented by averting cannabis use disorder.

SourceNIH/National Institute on Drug Abuse·JournalPsychological Medicine·DateMay 4, 2023

Exposure to cannabinoids in pregnancy increases newborn mortality and respiratory problems

A Brazilian study found that prenatal exposure to cannabinoids increases the risk of sudden infant death syndrome, breathing difficulties, and impaired control of breathing. The study suggests that consumption of cannabis or derivatives during pregnancy can have severe effects on the fetus's neural and physiological functions.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalBritish Journal of Pharmacology·DateApr 25, 2023

Cannabinoids give worms the munchies, too

A new study on nematode worms reveals that they react to cannabinoids in the same way as humans, increasing hunger for favorite foods and decreasing hunger for non-favored foods. The discovery emphasizes the commonality of cannabinoid effects across species.

SourceCell Press·JournalCurrent Biology·TypeExperimental study·DateApr 20, 2023

Legal cannabis markets linked to increased motor vehicle deaths

A new study from the University of Illinois Chicago found a substantial increase in crash fatalities in four states with legalized recreational cannabis, with an average 10% increase in motor vehicle accident deaths. The study suggests that investing in policies and public health initiatives may mitigate this harm.

SourceUniversity of Illinois Chicago·JournalSocial Science & Medicine·TypeData/statistical analysis·DateMar 27, 2023

Can cannabis use disorder be accurately diagnosed?

Researchers at Rutgers University propose a new approach to accurately diagnosing cannabis use disorder, particularly for individuals who use cannabis for therapeutic purposes. The current diagnostic manual may misdiagnose these individuals due to the rapid increase in state-level legalization of medical marijuana.

SourceRutgers University·JournalJAMA Psychiatry·TypeData/statistical analysis·DateMar 27, 2023

Dedicated protocol of hyperbaric oxygen therapy is more effective than the drug treatment available today for fibromyalgia caused by head injury

Researchers at Tel Aviv University found that dedicated hyperbaric oxygen therapy is more effective in reducing pain and healing patients with fibromyalgia caused by traumatic brain injury. The treatment resulted in significant improvements in 2 out of 5 patients, including improved pain threshold tests and quality of life indicators.

SourceTel-Aviv University·JournalPLOS ONE·DateMar 22, 2023

Hair analysis shows child drug use could be twice as high as we think

A study of over 1,300 children aged 9-13 found a significant increase in substance use when combining hair analysis with survey results, nearly doubling the estimated number of child drug users. This suggests that hair analysis is a more accurate method for assessing adolescent substance abuse than self-reporting alone.

SourceTaylor & Francis Group·JournalThe American Journal of Drug and Alcohol Abuse·TypeObservational study·DateMar 6, 2023